Table 2.
Patient no. | Donor KIR genotype |
Donor HLA KIR ligands |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibitory |
Activating |
HLA-Bw | HLA-C | |||||||||
2DL1 | 2DL2 | 2DL3 | 3DL1 | 2DS1 | 2DS2 | 2DS3 | 2DS4 | 2DS5 | 3DS1 | |||
1 | + | + | + | + | + | + | + | Bw6/Bw6 | C2/C2 | |||
2 | + | + | + | + | + | + | + | Bw6/Bw6 | C1/C1 | |||
3 | + | + | + | + | + | + | Bw6/Bw6 | C1/C2 | ||||
4 | + | + | + | + | + | Bw4/Bw6 | C1/C2 | |||||
5 | + | + | + | + | + | + | + | Bw4/Bw4 | C2/C2 | |||
6 | + | + | + | + | + | + | + | Bw6/Bw6 | C1/C2 | |||
7 | + | + | + | + | Bw4/Bw6 | C1/C2 | ||||||
8 | + | + | + | + | Bw6/Bw6 | C1/C2 | ||||||
9 | + | + | + | + | Bw4/Bw6 | C1/C1 | ||||||
10 | + | + | + | + | + | + | Bw4/Bw6 | C1/C2 | ||||
11 | + | + | + | + | + | + | + | Bw4/Bw6 | C1/C1 | |||
12 | + | + | + | + | + | + | + | + | + | + | Bw4/Bw6* | C2/C2 |
13 | + | + | + | + | + | + | + | + | Bw4/Bw6 | C1/C2 | ||
14 | + | + | + | + | + | + | + | + | + | Bw4/Bw4 | C1/C1 | |
15 | + | + | + | + | + | + | + | Bw4/Bw6* | C1/C2 | |||
16 | + | + | + | + | + | + | + | Bw6/Bw6 | C1/C1 |
+ indicates the presence of the gene in each person.
Individuals with Bw4 epitopes exclusively contributed by HLA-A antigens.